vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and STEWART INFORMATION SERVICES CORP (STC). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $764.6M, roughly 1.2× STEWART INFORMATION SERVICES CORP). STEWART INFORMATION SERVICES CORP runs the higher net margin — 2.2% vs 0.7%, a 1.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 27.7%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 12.7%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Stewart Information Services Corporation (SISCO) is a real estate information, title insurance and transaction management company. Wholly owned subsidiaries, Stewart Title Guaranty Co. and Stewart Title Company offer products and services in the United States and abroad through its direct retail operations, independent agencies in the Stewart Trusted Provider network, and other companies. Stewart Title is headquartered in Houston, Texas, and has approximately 6,350 employees.

ASTH vs STC — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.2× larger
ASTH
$950.5M
$764.6M
STC
Growing faster (revenue YoY)
ASTH
ASTH
+15.2% gap
ASTH
42.9%
27.7%
STC
Higher net margin
STC
STC
1.5% more per $
STC
2.2%
0.7%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
12.7%
STC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
STC
STC
Revenue
$950.5M
$764.6M
Net Profit
$6.6M
$17.0M
Gross Margin
Operating Margin
1.9%
Net Margin
0.7%
2.2%
Revenue YoY
42.9%
27.7%
Net Profit YoY
184.4%
448.4%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
STC
STC
Q1 26
$764.6M
Q4 25
$950.5M
$790.6M
Q3 25
$956.0M
$796.9M
Q2 25
$654.8M
$722.2M
Q1 25
$620.4M
$612.0M
Q4 24
$665.2M
$665.9M
Q3 24
$478.7M
$667.9M
Q2 24
$486.3M
$602.2M
Net Profit
ASTH
ASTH
STC
STC
Q1 26
$17.0M
Q4 25
$6.6M
$36.3M
Q3 25
$373.0K
$44.3M
Q2 25
$9.4M
$31.9M
Q1 25
$6.7M
$3.1M
Q4 24
$-7.8M
$22.7M
Q3 24
$16.1M
$30.1M
Q2 24
$19.2M
$17.3M
Operating Margin
ASTH
ASTH
STC
STC
Q1 26
Q4 25
1.9%
6.5%
Q3 25
2.0%
7.7%
Q2 25
3.1%
6.5%
Q1 25
3.3%
1.0%
Q4 24
0.1%
5.3%
Q3 24
5.9%
6.4%
Q2 24
6.2%
4.8%
Net Margin
ASTH
ASTH
STC
STC
Q1 26
2.2%
Q4 25
0.7%
4.6%
Q3 25
0.0%
5.6%
Q2 25
1.4%
4.4%
Q1 25
1.1%
0.5%
Q4 24
-1.2%
3.4%
Q3 24
3.4%
4.5%
Q2 24
3.9%
2.9%
EPS (diluted)
ASTH
ASTH
STC
STC
Q1 26
Q4 25
$0.12
$1.26
Q3 25
$0.01
$1.55
Q2 25
$0.19
$1.13
Q1 25
$0.14
$0.11
Q4 24
$-0.14
$0.81
Q3 24
$0.33
$1.07
Q2 24
$0.40
$0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
STC
STC
Cash + ST InvestmentsLiquidity on hand
$429.5M
$317.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
Total Assets
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
STC
STC
Q1 26
$317.5M
Q4 25
$429.5M
$369.7M
Q3 25
$463.4M
$233.2M
Q2 25
$342.1M
$223.8M
Q1 25
$260.9M
$194.2M
Q4 24
$290.8M
$257.5M
Q3 24
$350.3M
$228.7M
Q2 24
$327.7M
$176.7M
Total Debt
ASTH
ASTH
STC
STC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$445.8M
Q3 24
Q2 24
Stockholders' Equity
ASTH
ASTH
STC
STC
Q1 26
Q4 25
$779.3M
$1.6B
Q3 25
$775.5M
$1.5B
Q2 25
$765.5M
$1.4B
Q1 25
$745.4M
$1.4B
Q4 24
$712.7M
$1.4B
Q3 24
$704.6M
$1.4B
Q2 24
$678.9M
$1.4B
Total Assets
ASTH
ASTH
STC
STC
Q1 26
Q4 25
$2.2B
$3.3B
Q3 25
$2.2B
$2.8B
Q2 25
$1.4B
$2.8B
Q1 25
$1.3B
$2.7B
Q4 24
$1.4B
$2.7B
Q3 24
$1.3B
$2.7B
Q2 24
$1.3B
$2.6B
Debt / Equity
ASTH
ASTH
STC
STC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.32×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
STC
STC
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
STC
STC
Q1 26
Q4 25
$-2.9M
$89.5M
Q3 25
$10.0M
$92.6M
Q2 25
$90.9M
$53.4M
Q1 25
$16.6M
$-29.9M
Q4 24
$-10.9M
$68.0M
Q3 24
$34.0M
$76.1M
Q2 24
$23.2M
$21.1M
Free Cash Flow
ASTH
ASTH
STC
STC
Q1 26
Q4 25
$-6.0M
$62.3M
Q3 25
$7.4M
$73.6M
Q2 25
$89.5M
$38.7M
Q1 25
$13.6M
$-42.2M
Q4 24
$-13.5M
$55.6M
Q3 24
$31.7M
$67.4M
Q2 24
$20.4M
$11.9M
FCF Margin
ASTH
ASTH
STC
STC
Q1 26
Q4 25
-0.6%
7.9%
Q3 25
0.8%
9.2%
Q2 25
13.7%
5.4%
Q1 25
2.2%
-6.9%
Q4 24
-2.0%
8.4%
Q3 24
6.6%
10.1%
Q2 24
4.2%
2.0%
Capex Intensity
ASTH
ASTH
STC
STC
Q1 26
Q4 25
0.3%
3.4%
Q3 25
0.3%
2.4%
Q2 25
0.2%
2.0%
Q1 25
0.5%
2.0%
Q4 24
0.4%
1.9%
Q3 24
0.5%
1.3%
Q2 24
0.6%
1.5%
Cash Conversion
ASTH
ASTH
STC
STC
Q1 26
Q4 25
-0.44×
2.47×
Q3 25
26.69×
2.09×
Q2 25
9.65×
1.67×
Q1 25
2.48×
-9.73×
Q4 24
2.99×
Q3 24
2.11×
2.53×
Q2 24
1.21×
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

STC
STC

Agency title$333.0M44%
Direct title$270.2M35%
Real estate solutions$161.4M21%

Related Comparisons